← Leaderboards
Latha Dulipsingh
University Of Connecticut Sch Of Med/Dnt
$23,472
Attributed
$23,472
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$23,472 · 1
By mechanism
M01$23,472 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Karen M Prestwood$365,671
- Anne M Kenny$3,404,518
- Pamela Taxel$261,998
- Ernesto Canalis$18,979,065
- Carol C. Pilbeam$8,986,806
Others in their field
Top investigators on “Biomarker”
- David R. Weir · University Of Michigan At Ann Arbor$368,126,077
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,231,562
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$217,859,034
- Ralph Parchment · Leidos Biomedical Research, Inc.$186,322,680
- Randall J Bateman · Washington University$182,177,358
- Paul S. Aisen · Cognition Therapeutics, Inc.$182,141,353
Research focus
BiomarkerBone MetabolismClinical ResearchDiagnosis Design /EvaluationHuman SubjectHuman Therapy EvaluationMetabolism Disorder ChemotherapyMusculoskeletal Disorder DiagnosisOsteoporosisPhysiologic Bone ResorptionSkeletal Disorder ChemotherapyUrinalysis
Grant awards (7)
ASSESMENT OF BONE TURNOVER USING BIOCHEMICAL MARKERS IN RESPONSE TO TREATMENT$0
M01 · FY2002 · RR
ASSESMENT OF BONE TURNOVER USING BIOCHEMICAL MARKERS IN RESPONSE TO TREATMENT$4,361
M01 · FY2001 · RR
ASSESMENT OF BONE TURNOVER USING BIOCHEMICAL MARKERS IN RESPONSE TO TREATMENT$0
M01 · FY2001 · RR
ASSESMENT OF BONE TURNOVER USING BIOCHEMICAL MARKERS IN RESPONSE TO TREATMENT$0
M01 · FY2001 · RR
ASSESMENT OF BONE TURNOVER USING BIOCHEMICAL MARKERS IN RESPONSE TO TREATMENT$19,111
M01 · FY2000 · RR
ASSESMENT OF BONE TURNOVER USING BIOCHEMICAL MARKERS IN RESPONSE TO TREATMENT$0
M01 · FY2000 · RR
ASSESMENT OF BONE TURNOVER USING BIOCHEMICAL MARKERS IN RESPONSE TO TREATMENT$0
M01 · FY2000 · RR